Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

HIMS & HERS HEALTH, INC.

(HIMS)
  Report
Delayed Nyse  -  04:00:02 2023-01-27 pm EST
7.750 USD   +2.11%
01/18Hims & Hers Launches New Line of Volumizing Shampoos and Conditioners
BU
01/18Hims & Hers Health, Inc. Launches New Line of Volumizing Shampoos and Conditioners
CI
01/12Kristen Bell Partners With Hers As Its First Mental Health Ambassador
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/23/2023 01/24/2023 01/25/2023 01/26/2023 01/27/2023 Date
7.63(c) 7.64(c) 7.43(c) 7.59(c) 7.75(c) Last
2 442 516 1 637 582 1 526 029 1 284 360 1 338 019 Volume
+5.10% +0.13% -2.75% +2.15% +2.11% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 521 M - -
Net income 2022 -68,1 M - -
Net cash position 2022 59,9 M - -
P/E ratio 2022 -23,4x
Yield 2022 -
Sales 2023 718 M - -
Net income 2023 -35,9 M - -
Net cash position 2023 84,3 M - -
P/E ratio 2023 -44,0x
Yield 2023 -
Capitalization 1 610 M 1 610 M -
EV / Sales 2022 2,98x
EV / Sales 2023 2,13x
Nbr of Employees 398
Free-Float 75,0%
More Financials
Company
Hims & Hers Health, Inc., formerly Oaktree Acquisition Corp., is a telehealth platform that connects consumers to licensed healthcare professionals. The Company has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology,... 
More about the company
Ratings of Hims & Hers Health, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about HIMS & HERS HEALTH, INC.
01/18Hims & Hers Launches New Line of Volumizing Shampoos and Conditioners
BU
01/18Hims & Hers Health, Inc. Launches New Line of Volumizing Shampoos and Conditioners
CI
01/12Kristen Bell Partners With Hers As Its First Mental Health Ambassador
BU
01/10Tigress Financial Adjusts Price Target on Hims & Hers Health to $12 From $11, Keeps Buy..
MT
2022Hims & Hers Welcomes Back Dr. Pat Carroll as Chief Medical Officer
BU
2022Hims & Hers Appoints Dr. Pat Carroll as Chief Medical Officer
CI
2022Hims & Hers appoints first-ever Chief Pharmacy & Innovation Officer
BU
2022Hims & Hers Health, Inc Appoints Scott Knoer as Chief Pharmacy & Innovation Officer
CI
2022Hims & Hers Health to Collaborate With ChristianaCare to Offer In-Person Services, Expa..
MT
2022Hims & Hers and ChristianaCare Partner to Expand In-Person Healthcare Access in Four St..
BU
2022Hims & Hers Health, Inc. and ChristianaCare Partner to Expand In-Person Healthcare Acce..
CI
2022Deutsche Bank Adjusts Hims & Hers Health Price Target to $7 From $8, Maintains Hold Rat..
MT
2022Lyft, TripAdvisor fall; Five9, Hims & Hers rise
AQ
2022Hims & Hers Health Q3 Loss Widens, Revenue Rises; Raises Full-Year 2022 Revenue Outlook..
MT
2022Sector Update: Health Care Stocks Advance During Tuesday Trading
MT
More news
News in other languages on HIMS & HERS HEALTH, INC.
01/18Hims & Hers Health, Inc. lance une nouvelle gamme de shampooings et de revitalisants vo..
2022Hims & Hers nomme le Dr. Pat Carroll au poste de médecin en chef
2022Hims & Hers Health, Inc. nomme Scott Knoer au poste de directeur de la pharmacie et de ..
2022Hims & Hers Health va collaborer avec ChristianaCare pour proposer des services en pers..
2022Hims & Hers Health, Inc. et ChristianaCare s'associent pour étendre l'accès aux soins d..
More news
Analyst Recommendations on HIMS & HERS HEALTH, INC.
More recommendations
ETFs positioned on HIMS & HERS HEALTH, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
SPDR S&P Health Care Services ETF - USD1.46%0.85%United_States
Global X Telemedicine & Digital Health Dist - GBP1.29%2.35%-NC
Global X Telemedicine & Digital Health - USD1.29%2.37%-NC
Global X Telemedicine & Digital Health ETF - USD1.28%1.93%-NC
Defiance NextGen SPAC Derived ETF - USD0.13%-0.37%-NC
More ETFs positioned on HIMS & HERS HEALTH, INC.
Chart HIMS & HERS HEALTH, INC.
Duration : Period :
Hims & Hers Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HIMS & HERS HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 7,75 $
Average target price 8,40 $
Spread / Average Target 8,39%
EPS Revisions
Managers and Directors
Andrew Dudum Chairman & Chief Executive Officer
Oluyemi Okupe Chief Financial Officer
Patrick Carroll Chief Medical Officer & Director
Melissa Baird Chief Operating Officer
Alex Bard Independent Director